Induced pluripotent stem cells (IPS cells), generated by transcription factor-dependent nuclear reprogramming of differentiated somatic cells, are pluripotent stem cell lines that can be propagated indefinitely in culture and maintain the potential to differentiate into any cell type in the body. As iPS cells retain the same genetic make-up as the somatic cell targeted for reprogramming, these cells hold tremendous promise for uncovering novel genetic and biochemical factors that underiie diseases with complex and pooriy understood genetic influences, such as diabetes. The DRC iPS Core will establish and maintain a centralized facility for the reliable and consistent generation and propagation of reprogrammed IPS cells for use in cutting-edge research into the molecular and cellular pathologies underiying diabetes and its complications. The Core will enhance the scientific productivity of DRC projects in multiple ways: (1) By standardizing medical assessments and data collection from human subjects, as well as cell isolation protocols and reagents, the Core will allow direct comparison of data across projects and remove variability resulting from potential technical or biological differences in patient populations or cell handling. (2) As IPS cell production and propagation can be technically challenging, the Core will ensure reproducibility and comparability of results, by enforcing rigorous standards of quality control. (3) The Core will provide advanced training for investigators desiring to introduce IPS technologies into their own laboratories, increasing the currently small number of laboratories in the Boston area skilled in the isolation and culture of IPS cells. (4) The Core will provide expert advice on experimental design, regulatory documentation and interpretation of results, based on the extensive expertise of the Core Directors and Staff. (5) As the Core will be utilized by multiple labs, it will provide a venue for scientific interaction, fostering greater exchange of information among DRC Investigators and promoting productive collaborations with other Boston-based research groups. (6) The Core will help to develop new technologies that support center activities, including most notably the optimization of methods for deriving iPS cells from people with diabetes and the integration of new reprogramming technologies, including integration-free IPS generation and generation ofiPS cells from peripheral blood samples, as these become robust and available. These activities will benefit DRC Investigators and significantly accelerate advances in diabetes research.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-S)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Joslin Diabetes Center
United States
Zip Code
Commissariat, Persis V; Volkening, Lisa K; Guo, Zijing et al. (2018) Associations between major life events and adherence, glycemic control, and psychosocial characteristics in teens with type 1 diabetes. Pediatr Diabetes 19:85-91
Barbour, Linda A; Scifres, Christina; Valent, Amy M et al. (2018) A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. Am J Obstet Gynecol 219:367.e1-367.e7
Lammer, Jan; Karst, Sonja G; Lin, Michael M et al. (2018) Association of Microaneurysms on Adaptive Optics Scanning Laser Ophthalmoscopy With Surrounding Neuroretinal Pathology and Visual Function in Diabetes. Invest Ophthalmol Vis Sci 59:5633-5640
Gordin, Daniel; King, George L (2018) Response to Comment on Gordin et al. Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes. Diabetes Care 2018;41:815-822. Diabetes Care 41:e128
Karatepe, Kutay; Zhu, Haiyan; Zhang, Xiaoyu et al. (2018) Proteinase 3 Limits the Number of Hematopoietic Stem and Progenitor Cells in Murine Bone Marrow. Stem Cell Reports 11:1092-1105
Sustarsic, Elahu G; Ma, Tao; Lynes, Matthew D et al. (2018) Cardiolipin Synthesis in Brown and Beige Fat Mitochondria Is Essential for Systemic Energy Homeostasis. Cell Metab 28:159-174.e11
Lessard, Sarah J; MacDonald, Tara L; Pathak, Prerana et al. (2018) JNK regulates muscle remodeling via myostatin/SMAD inhibition. Nat Commun 9:3030
Cardamone, Maria Dafne; Tanasa, Bogdan; Cederquist, Carly T et al. (2018) Mitochondrial Retrograde Signaling in Mammals Is Mediated by the Transcriptional Cofactor GPS2 via Direct Mitochondria-to-Nucleus Translocation. Mol Cell 69:757-772.e7
Solheim, Marie H; Winnay, Jonathon N; Batista, Thiago M et al. (2018) Mice Carrying a Dominant-Negative Human PI3K Mutation Are Protected From Obesity and Hepatic Steatosis but Not Diabetes. Diabetes 67:1297-1309
Stanford, Kristin I; Lynes, Matthew D; Takahashi, Hirokazu et al. (2018) 12,13-diHOME: An Exercise-Induced Lipokine that Increases Skeletal Muscle Fatty Acid Uptake. Cell Metab 27:1111-1120.e3

Showing the most recent 10 out of 1120 publications